Using video logs to improve access to HIV prevention for Black women in Texas

Leveraging video logs as a bridge to pre-exposure prophylaxis (PrEP) with tailored messaging to Black women and their healthcare providers in Texas

NIH-funded research University of Texas Hlth Sci Ctr Houston · NIH-10915265

This study is working to help more Black women in Texas feel comfortable using a medication called PrEP to prevent HIV by sharing helpful videos that address their concerns and connect them with healthcare providers.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10915265 on NIH RePORTER

What this research studies

This research aims to enhance the use of pre-exposure prophylaxis (PrEP) among cisgender Black women (CBW) in Texas by utilizing a video-log series that communicates tailored messages. The project focuses on addressing barriers such as medical mistrust and stigma that hinder PrEP uptake. By collaborating with community health centers and leveraging social media, the study seeks to foster connections between CBW and healthcare providers, ultimately increasing both the willingness to initiate PrEP and the willingness of providers to prescribe it. The intervention is designed to create a supportive environment that encourages open communication about HIV prevention.

Who could benefit from this research

Good fit: Ideal candidates for this research are cisgender Black women in Texas who are at risk for HIV and eligible for PrEP.

Not a fit: Patients who are not at risk for HIV or who do not identify as cisgender Black women may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly increase the number of Black women using PrEP, thereby reducing their risk of contracting HIV.

How similar studies have performed: Previous research has shown that targeted health communication strategies can effectively increase PrEP uptake among underserved populations, suggesting potential success for this approach.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.